Fumitoshi Hirayama focuses on Cyclodextrin, Chromatography, Solubility, Drug carrier and Stereochemistry. His research in the fields of Inclusion compound overlaps with other disciplines such as Conjugate. His Chromatography study incorporates themes from Oral administration and Pharmacology toxicology.
His research integrates issues of Stability constants of complexes, Aqueous solution, Bioavailability and Dissolution in his study of Solubility. The concepts of his Drug carrier study are interwoven with issues in Combinatorial chemistry and Dosage form. His Combinatorial chemistry study integrates concerns from other disciplines, such as Targeted drug delivery and 2 hydroxypropyl β cyclodextrin.
Fumitoshi Hirayama mostly deals with Cyclodextrin, Solubility, Chromatography, Stereochemistry and Organic chemistry. His work on Inclusion compound as part of general Cyclodextrin study is frequently linked to Conjugate, bridging the gap between disciplines. His biological study deals with issues like Dissolution, which deal with fields such as Nuclear chemistry and Absorption.
As a part of the same scientific study, he usually deals with the Chromatography, concentrating on Bioavailability and frequently concerns with Oral administration, Intestinal absorption and Absorption. His Stereochemistry research includes elements of Hemolysis and Carboxylic acid. As a member of one scientific family, Fumitoshi Hirayama mostly works in the field of Dosage form, focusing on Drug carrier and, on occasion, Combinatorial chemistry.
Fumitoshi Hirayama spends much of his time researching Cyclodextrin, Oxidative stress, Chromatography, Antioxidant and Nuclear chemistry. His research in Cyclodextrin intersects with topics in Ether, Self-healing hydrogels, Polymer chemistry, Insulin and Solubility. Fumitoshi Hirayama has included themes like Cationic polymerization, Stability constants of complexes, Drug carrier and Glimepiride in his Solubility study.
His Oxidative stress research is multidisciplinary, incorporating perspectives in Chronic renal failure, Gastrointestinal tract and Pharmacology. His work carried out in the field of Chromatography brings together such families of science as Rheology, Dynamic mechanical analysis, Micelle, Aqueous solution and Polysaccharide. Fumitoshi Hirayama has researched Nuclear chemistry in several fields, including Benzyl acetate, Radical, Beta-Cyclodextrins and Dissolution.
Fumitoshi Hirayama focuses on Antioxidant, Chromatography, Cyclodextrin, Oxidative stress and Chitosan. His studies in Chromatography integrate themes in fields like Denaturation and Circular dichroism. His Cyclodextrin study combines topics in areas such as Crystallization, Amorphous solid, Crystallography, Polymer chemistry and Freeze-drying.
His study on Oxidative stress also encompasses disciplines like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cyclodextrin Drug Carrier Systems.
Kaneto Uekama;Fumitoshi Hirayama;Tetsumi Irie.
Chemical Reviews (1998)
Cyclodextrin-based controlled drug release system.
F Hirayama;K Uekama.
Advanced Drug Delivery Reviews (1999)
Enhancement of gene expression by polyamidoamine dendrimer conjugates with alpha-, beta-, and gamma-cyclodextrins.
Hidetoshi Arima;Fumihiro Kihara;Fumitoshi Hirayama;Kaneto Uekama.
Bioconjugate Chemistry (2001)
Inclusi on complexations of steroid hormones with cyclodextrins in water and in solid phase
K Uekama;T Fujinaga;F Hirayama;M Otagiri.
International Journal of Pharmaceutics (1982)
In vitro and in vivo gene transfer by an optimized α-cyclodextrin conjugate with polyamidoamine dendrimer
Fumihiro Kihara;Hidetoshi Arima;Toshihito Tsutsumi;Fumitoshi Hirayama.
Bioconjugate Chemistry (2003)
Improvement of gene delivery mediated by mannosylated dendrimer/α-cyclodextrin conjugates
Koki Wada;Hidetoshi Arima;Toshihito Tsutsumi;Yuko Chihara.
Journal of Controlled Release (2005)
Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with α-cyclodextrin
Fumihiro Kihara;Hidetoshi Arima;Toshihito Tsutsumi;Fumitoshi Hirayama.
Bioconjugate Chemistry (2002)
Evaluation of polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA)
Toshihito Tsutsumi;Fumitoshi Hirayama;Kaneto Uekama;Hidetoshi Arima.
Journal of Controlled Release (2007)
Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
Hidetoshi Arima;Kiyokazu Yunomae;Kouzou Miyake;Tetsumi Irie.
Journal of Pharmaceutical Sciences (2001)
Determination of the Stability Constants for Inclusion Complexes of Cyclodextrins with Various Drug Molecules by High Performance Liquid Chromatography
Kaneto Uekama;Fumitoshi Hirayama;Shouzo Nasu;Naoki Matsuo.
Chemical & Pharmaceutical Bulletin (1978)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Sojo University
Daiichi University of Pharmacy
Sojo University
Kumamoto University
Freie Universität Berlin
National University of Singapore
Macquarie University
Okayama University
University of Göttingen
Mukogawa Women's University
Delft University of Technology
École Polytechnique Fédérale de Lausanne
New York University Abu Dhabi
North Carolina State University
University of Miami
University of Bologna
Instituto Superior Técnico
Rice University
Newcastle University
National Chemical Laboratory
Antoni van Leeuwenhoek Hospital
University of Reading
Oregon Health & Science University
Queen's University Belfast
Jichi Medical University
Wageningen University & Research